 |
|
 |
 |

Home > Company Index > Drugs > Diagnostic Substances > Caprius, Inc.
 |
Caprius, Inc. |
 |
 |
 |
PROFILE |
 |
Caprius isn't capricious, but it has changed its strategy. The company still owns Strax Institute in Lauderhill, Florida, which provides comprehensive breast care services, performing some 25,000 procedures annually. But Caprius' main activities are now in the therapeutic drug monitoring industry, and centered around its Innofluor line of diagnostic assays, which monitor intake levels of more than a dozen therapeutic drugs, such as Johnson & Johnson's Toprimate and Aventis' Teicoplanin. Caprius acquired Opus Diagnostics in 1999; at the same time, Opus aquired Oxis Health Products and its assay technology (which included the Innofluor line). Caprius sells its products in more than 20 countries.
COMPETITION |
 |
Abbott Laboratories (ABT)
Roche Group (ROHHY)
Sigma-Aldrich Corporation (SIAL)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: September
2000 Sales (mil.): 3.40
1-Yr. Sales Growth: 3.8%
Employees: 17
Revenue per employee: $200,000.00
KEY PEOPLE |
 |
George Aaron
CEO
Jonathan Joels
CFO
CONTACT INFO |
 |
1 Parker Plaza
Fort Lee, NJ 07024
US
Phone: 201-592-8838
Fax: 201-592-0393
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |